| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/17/2003 | US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 04/17/2003 | US20030073627 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 04/17/2003 | US20030073626 Compositions and methods for treating peripheral vascular disease |
| 04/17/2003 | US20030073625 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial IB-367 peptides |
| 04/17/2003 | US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering |
| 04/17/2003 | US20030073621 Antidiabetic agents; isolated nucleic acid; genetic engineering |
| 04/17/2003 | US20030073620 Genetic engineering; antibody binding to nucleic acid; disease therapy |
| 04/17/2003 | US20030073619 Branched polyethylenimine |
| 04/17/2003 | US20030073618 Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof |
| 04/17/2003 | US20030073616 Hair growth; controlling apolecia |
| 04/17/2003 | US20030073614 Methods for affecting various diseases utilizing LXR compounds |
| 04/17/2003 | US20030073609 Enhanced pharmacokinetic profile of intradermally delivered substances |
| 04/17/2003 | US20030073237 Expression vector for use as gene therapeutic tool in the treatment of heart defects |
| 04/17/2003 | US20030073236 Adjusting cell cycle activity in sample; obtain cell, reduce expression of preferential protein in signal transduction pathway, monitor adjustment in cell cycle activity |
| 04/17/2003 | US20030073216 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073215 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073214 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073213 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073212 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073211 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073210 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073208 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 04/17/2003 | US20030073207 Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors |
| 04/17/2003 | US20030073199 Nucleotide sequences coding polypeptides for use in the treatment of rheumatic and rheumatoid arthritis |
| 04/17/2003 | US20030073190 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
| 04/17/2003 | US20030073166 Haemophilus adherence and penetration proteins |
| 04/17/2003 | US20030073162 Protein for use in the diagnosis, treatment and prevention of cancer |
| 04/17/2003 | US20030073161 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and immunological disorders |
| 04/17/2003 | US20030073159 Nucleotide sequences coding polypeptide for use in the treatment of tumors and viral diseases |
| 04/17/2003 | US20030073157 Synthetic peptides, conjugation reagents and methods |
| 04/17/2003 | US20030073144 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 04/17/2003 | US20030073142 Immunoglobulin E vaccines and methods of use thereof |
| 04/17/2003 | US20030073131 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
| 04/17/2003 | US20030073130 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
| 04/17/2003 | US20030073120 Nucleotide sequences coding polypeptide for use in the treatment of signal tranduction defects |
| 04/17/2003 | US20030073117 Novel protein and gene encoding the protein |
| 04/17/2003 | US20030073115 Regulation of human galanin receptor-like g protein coupled receptor |
| 04/17/2003 | US20030073099 Novel nucleic acids and polypeptides |
| 04/17/2003 | US20030073095 Nucleotide sequences coding bacterial protein for use in the treatment and prevention of bacterial infections |
| 04/17/2003 | US20030073087 Phospholipase for use in the prevention and treatment of inflammatory, cancer, heart, brain, lung, ischemic and respiratory disorders |
| 04/17/2003 | US20030073084 ING-encoded p33ING1 protein as a mediator of p53 signaling pathway in mammalian cells |
| 04/17/2003 | US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development |
| 04/17/2003 | US20030073079 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders |
| 04/17/2003 | US20030073077 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders |
| 04/17/2003 | US20030073076 Analyzing modulators or treatments of fibroproliferative diseases; obtain sample, incubate with modulator, monitor marker expression, decreased expression indicate effective modulator |
| 04/17/2003 | US20030072814 Topical pharmaceutical composition for the treatment of warts |
| 04/17/2003 | US20030072797 Pharmaceutical compositions for oral administration |
| 04/17/2003 | US20030072796 For activating T lymphocytes in vitro for the treatment of disease conditions |
| 04/17/2003 | US20030072795 For therapy and prophylaxis of skin disorders |
| 04/17/2003 | US20030072785 Mixtures for stimulating glucose up-take |
| 04/17/2003 | US20030072783 Administering nitric oxide adduct to a damaged vascular surface, wherein damaged vascular surface is interior surface of a blood vessel in which damage to endothelium or subendothelium, narrowing or stenosis of vessel has occured |
| 04/17/2003 | US20030072769 Used in the manufacture of vaccines, therapy, prophylaxis, drug screening |
| 04/17/2003 | US20030072767 Compositions and methods for WT1 specific immunotherapy |
| 04/17/2003 | US20030072766 Comprising antiserum raised against a flagellaless Campylobacter strain for prophylaxis of Campylobacter colonisation in animals |
| 04/17/2003 | US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions |
| 04/17/2003 | US20030072762 For enhancing Fc receptor-mediated antigen presentation, vaccines |
| 04/17/2003 | US20030072761 Providing a polypeptide in association with an insulin-like grwoth factor (IGF) moiety to a mammal, thereby resulting in accumulation of the polypeptide in the brain of mammal |
| 04/17/2003 | US20030072759 Administering to a patient afflicted with a gastrointestinal tumor, a murine monoclonal antibody which specifically binds to an epitope of 17-1A antigen, the antibody being administered parenterally in multiple doses |
| 04/17/2003 | US20030072758 BMPR1A involvement in juvenile polyposis |
| 04/17/2003 | US20030072757 For use in research, diagnostic, and therapeutic agent screening applications |
| 04/17/2003 | US20030072756 Combination therapy using an IL-1 inhibitor and methotrexate |
| 04/17/2003 | US20030072755 Administering antibody to a protein component or to a carbohydrate-protein component of P-selectin glycoprotein ligand for therapy of rheumatoid arthritis |
| 04/17/2003 | US20030072754 CD154 blockade therapy for pancreatic islet tissue transplantation |
| 04/17/2003 | US20030072753 Virus-like particles for the induction of autoantibodies |
| 04/17/2003 | US20030072752 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/17/2003 | US20030072750 For promoting the healing of skin |
| 04/17/2003 | US20030072749 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve |
| 04/17/2003 | US20030072748 Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (Kca) |
| 04/17/2003 | US20030072747 Platelet-activating factor acetylhydrolase |
| 04/17/2003 | US20030072745 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030072744 Delivering a vector to the heart of patient, vector comprising a transgene coding for a cardiomyocyte-differentiating peptide for improving or maintaining cardiac function |
| 04/17/2003 | US20030072742 Enhancement of immune response using targeting molecules |
| 04/17/2003 | US20030072740 Pulmonary delivery of active agents |
| 04/17/2003 | US20030072739 Stimulating neutrophilic function by administering mammalian midkine, or a derivative thereof, as an active ingredient, and inhibiting neutrophilic functino by administering inhibitor of mammalian midkine, or a derivative thereof |
| 04/17/2003 | US20030072738 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
| 04/17/2003 | US20030072737 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 04/17/2003 | US20030072736 Human tumor necrosis factor receptor TR16 |
| 04/17/2003 | US20030072732 Comprises association between elastase inhibitor compound of the N-acylaminoamide family and at least one antiinflammatory compound; for improving skin ageing and/or photoageing signs by slowing down connective tissue alterations |
| 04/17/2003 | US20030072724 Topical pharmaceutical composition to treat hyperpigmentation of the skin |
| 04/17/2003 | US20030072718 Spray drying to produce stable, high-potency dry powder formulations; utility in pulmonary delivery of interferons |
| 04/17/2003 | US20030071418 Method and device for playing an improved game of blackjack |
| 04/17/2003 | CA2464662A1 Modulation of the expression of genes dependent on stat-1 |
| 04/17/2003 | CA2463442A1 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2463133A1 Styryl acrylonitrile compounds and their use to promote myelopoiesis |
| 04/17/2003 | CA2462900A1 Reagents and methods useful for detecting diseases of the breast |
| 04/17/2003 | CA2462892A1 Human 3 relaxin |
| 04/17/2003 | CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis |
| 04/17/2003 | CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | CA2462858A1 Low molecular weight gtpase rhot |
| 04/17/2003 | CA2462791A1 Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof |
| 04/17/2003 | CA2462291A1 Methods and compositions for treating dermal lesions |
| 04/17/2003 | CA2462209A1 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |
| 04/17/2003 | CA2461900A1 Leukocyte inactivation module |
| 04/17/2003 | CA2461655A1 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | CA2461429A1 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | CA2461343A1 Mammalian c-type lectins |
| 04/17/2003 | CA2461064A1 Inhibition of stat-1 |
| 04/17/2003 | CA2461048A1 Liposome-encapsulated insulin formulations |